Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer Is ‘Still Confident’ in Xarelto Trial After FDA Comments
Bloomberg
Tuesday, September 6, 2011 - 12:14pm
tags:
FDA, bloodthinners, JNJ, Bayer, Xarelto
FDA Panel Considers Bone-Drug Safety
WSJ Online
Tuesday, September 6, 2011 - 12:13pm
tags:
FDA, biophosphonates, osteoporosis
Johnson & Johnson Stroke Drug Hammered by FDA Staff
Minyanville
Tuesday, September 6, 2011 - 12:12pm
tags:
Xarelto, stroke, JNJ, FDA, Bayer
Vertex Arthritis Pill Shines in Mid-Stage Study
TheStreet.com
Tuesday, September 6, 2011 - 12:10pm
tags:
Vertex, rheumatoid arthritis, VX-509
Novartis fights patent rejection in Indian court
Yahoo/AP
Tuesday, September 6, 2011 - 12:09pm
tags:
India, Gleevec, Novartis, cancer
Novartis gets European approval for Afinitor
Marketwatch
Tuesday, September 6, 2011 - 11:46am
tags:
Novartis, Europe, Afinitor
Top GSK scientist urges Alzheimer’s push
FT.com
Tuesday, September 6, 2011 - 11:44am
tags:
GSK, Alzheimer's disease
Extraordinary Restructure Of Valeant Pharmaceuticals
GuruFocus
Sunday, September 4, 2011 - 10:35am
tags:
Valeant Pharmaceuticals
Protalix BioTherapeutics: Near-Term Catalysts With Big Upside Potential
Seeking Alpha
Sunday, September 4, 2011 - 10:27am
tags:
Protalix BioTherapeutics, Gaucher disease, taliglucerase alfa
A Hidden Reason Why the Future Looks Bright for Jazz Pharmaceuticals
Motley Fool
Sunday, September 4, 2011 - 10:23am
tags:
Jazz Pharmaceuticals
Death of Medicis CEO’s Girlfriend Was a Suicide, Not a Crime, Sheriff Says
Bloomberg
Saturday, September 3, 2011 - 9:09am
tags:
Jonah Shacknai, Medicis
[video] The Next Big Thing In Biotech: Exelixis
TheStreet.com
Friday, September 2, 2011 - 2:15pm
tags:
Exelixis
FDA Action Date for Salix's Relistor
Yahoo/Zacks.com
Friday, September 2, 2011 - 2:14pm
tags:
FDA, Salix, Relistor, Progenics Pharmaceuticals
Vivus says FDA accepts application on ED drug
Yahoo/AP
Friday, September 2, 2011 - 2:13pm
tags:
FDA, Vivus, erectile dysfunction, Avanafil
Top 10 Biotech Stocks Loved By Hedge Funds
Seeking Alpha
Friday, September 2, 2011 - 2:11pm
tags:
Gilead, Cephalon, Amgen, Life Technologies, Biogen Idec, Illumina, Medicis, NPS Pharmaceuticals, Charles River Laboratories, Dendreon
Survey Says Oncologists Not So Hot On Provenge
Forbes
Friday, September 2, 2011 - 2:10pm
tags:
oncologists, Provenge, Dendreon, prostate cancer
AstraZeneca Falls as Crestor Study Results Not Significant
Bloomberg
Friday, September 2, 2011 - 12:54pm
tags:
Crestor, AstraZeneca, Pfizer, Lipitor, statins
Next Week Could Be Big for Johnson & Johnson: Analyst
Barron's
Friday, September 2, 2011 - 12:13pm
tags:
JNJ, bloodthinners, Xarelto
Sanofi: We'll sell generic Lipitor in France
Yahoo/AP
Friday, September 2, 2011 - 12:11pm
tags:
Lipitor, generics, Sanofi, France, Pfizer, statins
Baxter sues Teva over propofol liability suits
Fierce Pharma
Thursday, September 1, 2011 - 12:38pm
tags:
Baxter, propofol, Teva Pharmaceuticals, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.